CA2336262A1 - Tri de nexines - Google Patents

Tri de nexines Download PDF

Info

Publication number
CA2336262A1
CA2336262A1 CA002336262A CA2336262A CA2336262A1 CA 2336262 A1 CA2336262 A1 CA 2336262A1 CA 002336262 A CA002336262 A CA 002336262A CA 2336262 A CA2336262 A CA 2336262A CA 2336262 A1 CA2336262 A1 CA 2336262A1
Authority
CA
Canada
Prior art keywords
polynucleotide
snexn
polypeptide
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002336262A
Other languages
English (en)
Inventor
Henry Yue
Y. Tom Tang
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336262A1 publication Critical patent/CA2336262A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

L'invention porte sur le tri de nexines humaines (SNEXN) et sur des polynucléotides identifiant les SNEXN et codant pour elles. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes, ainsi que sur des procédés de diagnostic, traitement et prévention de troubles associés à l'expression des SNEXN.
CA002336262A 1999-05-27 2000-05-26 Tri de nexines Abandoned CA2336262A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13674099P 1999-05-27 1999-05-27
US60/136,740 1999-05-27
US13956699P 1999-06-16 1999-06-16
US60/139,566 1999-06-16
PCT/US2000/014831 WO2000073334A2 (fr) 1999-05-27 2000-05-26 Tri de nexines

Publications (1)

Publication Number Publication Date
CA2336262A1 true CA2336262A1 (fr) 2000-12-07

Family

ID=26834597

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336262A Abandoned CA2336262A1 (fr) 1999-05-27 2000-05-26 Tri de nexines

Country Status (5)

Country Link
EP (1) EP1124951A2 (fr)
JP (1) JP2003503016A (fr)
AU (1) AU5048200A (fr)
CA (1) CA2336262A1 (fr)
WO (1) WO2000073334A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3956179B2 (ja) 1999-09-17 2007-08-08 富士フイルム株式会社 ビデオ画像の製作方法及び装置
US6943242B2 (en) * 2001-05-07 2005-09-13 Amersham Biosciences Corp. Design of artificial genes for use as controls in gene expression analysis systems
WO2003046126A2 (fr) * 2001-10-24 2003-06-05 Amersham Biosciences (Sv) Corp Genes artificiels utilises comme temoins dans des systemes d'analyse de l'expression genique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804412A (en) * 1996-04-01 1998-09-08 The Regents Of The University Of California Nucleic acids encoding sorting nexins and methods of using same
JP2002519000A (ja) * 1998-01-28 2002-07-02 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｉｉ

Also Published As

Publication number Publication date
AU5048200A (en) 2000-12-18
EP1124951A2 (fr) 2001-08-22
JP2003503016A (ja) 2003-01-28
WO2000073334A2 (fr) 2000-12-07
WO2000073334A3 (fr) 2001-04-05

Similar Documents

Publication Publication Date Title
CA2431493A1 (fr) Aminoacyl arnt synthetases
WO2001005970A2 (fr) Proteines associees de liaison gtp
WO2001072777A2 (fr) Facteurs de transcription
CA2405781A1 (fr) Proteines secretees
US20050227277A1 (en) Apoptosis proteins
WO2000070047A2 (fr) Molecules completes exprimees dans des tissus humains
WO2000077040A2 (fr) Molecules de signalisation intracellulaires
WO2000078954A2 (fr) Proteines de regulateur de transcription humaines
WO2001019860A2 (fr) Proteines associees a la differenciation cellulaire
WO2001046256A2 (fr) Proteines circulant par l'intermediaire de vesicules
EP1299546A2 (fr) Aminoacyl arnt synthetases
CA2336262A1 (fr) Tri de nexines
WO2002048362A2 (fr) Proteines associees a l'embryogenese
CA2378989A1 (fr) Proteines humaines de domaine lim
WO2002046413A2 (fr) Molecules pour la detection et le traitement de maladies
CA2375407A1 (fr) Proteines du metabolisme de l'arn
CA2402747A1 (fr) Molecules associees a la proteine g
CA2390689A1 (fr) Lyases humaines et proteines associees
CA2409342A1 (fr) Messagers extracellulaires
CA2374222A1 (fr) Proteines associees au cytosquelette
CA2425767A1 (fr) Lipocalines
CA2417676A1 (fr) Sequences pour l'integrine alpha-8
CA2379133A1 (fr) Proteines humaines impliquees dans la detoxification
CA2378930A1 (fr) Proteines de transfert d'electrons
US20050059110A1 (en) Human nervous system-associated proteins

Legal Events

Date Code Title Description
FZDE Dead